Patent · US Expired

Transgeneic animal expressing a multiple mutated form of presenilin 1

US8492610B1 · kind B1 · utility

0Cited by

2References

2Claims

0Family size

Assignee

AVENTIS PHARMA S.A. · FR

Inventors

Anne Eckert · Mannheim, DE
Walter Muller · Neuwied, DE
Christian Czech · Weil am Rhein, DE
Laurent Pradier · Jouy-le-Moutier, FR
Gunter Tremp · Palaiseau, FR

Key dates

Filing date	Sep 22, 2000
Grant date	Jul 23, 2013
Priority date	—
Expiry date	Jan 24, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA01K2267/0312
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to the field of transgenic animal models and more particularly the animal models of Alzheimer's disease. The invention relates to a transgenic animal expressing a multimutated form of presenilin 1 and allowing an apoptotic phenomenon to be detected in a renewable peripheral tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.